Gunpo, South Korea

Yoonseok Song

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medytox Inc.. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoonseok Song: Innovator in Bile Acid Preparation

Introduction

Yoonseok Song is a notable inventor based in Gunpo-si, South Korea. He has made significant contributions to the field of pharmaceutical and cosmetic chemistry. His innovative methods for preparing bile acids have garnered attention in the scientific community.

Latest Patents

Yoonseok Song holds 1 patent related to methods for preparing bile acids. The patent details methods for synthesizing cholic acid, deoxycholic acid, and chenodeoxycholic acid, along with their esters and pharmaceutically acceptable salts. The methods utilize plant-derived steroids, such as dehydroepiandrosterone (DHEA) or Acetyl-dehydroepiandrosterone (Ac-DHEA), as starting materials. Additionally, the patent includes pharmaceutical and cosmetic compositions that are free of animal-derived impurities, ensuring high purity.

Career Highlights

Yoonseok Song is currently associated with Medytox Inc., a company known for its advancements in biopharmaceuticals. His work focuses on developing innovative methods that enhance the quality and efficacy of bile acid preparations.

Collaborations

Yoonseok collaborates with esteemed colleagues, including Dejun Liu and Yingzhe Qian. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Yoonseok Song's contributions to the preparation of bile acids represent a significant advancement in pharmaceutical and cosmetic applications. His innovative methods and collaborations continue to influence the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…